Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase EARLY_PHASE1 1Phase 2 1Phase 1/2 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 1056Neoplasms 890Prostatic Neoplasms 509Lung Neoplasms 426Colorectal Neoplasms 356Motor Activity 227Head and Neck Neoplasms 193Uterine Cervical Neoplasms 192Carcinoma, Non-Small-Cell Lung 182Brain Neoplasms 173Pancreatic Neoplasms 163Ovarian Neoplasms 141Colonic Neoplasms 138Carcinoma, Hepatocellular 136Anxiety Disorders 125Rectal Neoplasms 119Hematologic Neoplasms 115Multiple Myeloma 108Stomach Neoplasms 105Neoplasm Metastasis 100Precursor Cell Lymphoblastic Leukemia-Lymphoma 98Depression 94Melanoma 93Urinary Bladder Neoplasms 88Pain 88Endometrial Neoplasms 86Disease 85Lymphoma 84Glioblastoma 83Sarcoma 78

Interventions

Hearing Tests 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Ototoxicity × 1 year × Clear all
NCT06036407 2026-04-14

HEAR

University of Bern

Phase NA Completed
476 enrolled

Ototoxicity, Neoplasms, Hearing Loss

NCT05789316 2026-01-12

Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)

Washington University School of Medicine

Phase NA Completed
55 enrolled
Head & Neck

Ototoxicity, Head and Neck Neoplasms, Hearing Loss

NCT05936034 2025-11-28

PROTOTOX

Institut de Cancérologie de Lorraine

Phase NA Recruiting
52 enrolled

Ototoxicity, Hearing Disorders, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡